Advanced Oncotherapy PLC Rating Reiterated by Westhouse Securities (AVO)
Advanced Oncotherapy PLC (LON:AVO)‘s stock had its “buy” rating reaffirmed by analysts at Westhouse Securities in a research report issued to clients and investors on Monday. They currently have a GBX 9 ($0.15) target price on the stock. Westhouse Securities’ price objective indicates a potential upside of 210.34% from the stock’s previous close.
Shares of Advanced Oncotherapy PLC (LON:AVO) opened at 2.76 on Monday. Advanced Oncotherapy PLC has a 1-year low of GBX 1.60 and a 1-year high of GBX 3.149. The stock’s 50-day moving average is GBX 2.60 and its 200-day moving average is GBX 3.04.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.